To conduct the following evaluations in Korean healthy male adult volunteers receiving a single and multiple doses of MP-424 tablets: * Pharmacokinetics of MP-424 after a single and multiple doses. * Safety and tolerability of single and multiple doses of MP-424.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
26
Unnamed facility
Seoul, South Korea
MP-424 area under the plasma concentration-time curve (AUC) from 0 to infinity in Korean healthy volunteers
Time frame: up to 1 week
Number of participants with adverse events as a measure of safety and tolerability in Korean healthy volunteers
Time frame: up to 2 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Multiple